(Q68203403)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315612%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315612%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

1 reference

1 reference

E S Johnson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315612%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

R J Cregeen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315612%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315612%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315612%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

33 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315612%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

298-311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3315612%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-198700333-00058

22 September 2019

exact match

0 references

cites work

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

1 reference

12 December 2020

Randomised multicentre trial of anisoylated plasminogen streptokinase activator complex versus heparin. Interim results

1 reference

12 December 2020

Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Tolerance data

1 reference

12 December 2020

Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study

1 reference

12 December 2020

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

12 December 2020

Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States

1 reference

12 December 2020

Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction

1 reference

12 December 2020

Systemic effects of anisoylated plasminogen streptokinase activator complex and streptokinase therapy in acute myocardial infarction. Coagulation aspects of the Dutch Invasive Reperfusion Study

1 reference

12 December 2020

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)

1 reference

12 December 2020

Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.

1 reference

12 December 2020

Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study

1 reference

12 December 2020

Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Efficacy data

1 reference

12 December 2020

Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.

1 reference

12 December 2020

Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands

1 reference

12 December 2020

Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction

1 reference

12 December 2020

Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarction

1 reference

12 December 2020

Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction

1 reference

12 December 2020

Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex

1 reference

12 December 2020

Intravenous streptokinase given within 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2

1 reference

12 December 2020